Clarithromycin
The elevated cardiovascular death risk from clarithromycin persists after the medication is stopped. Taking clarithromycin is associated with a 27% increased risk of dying, primarily from cardiovascular events such as heart attack and arrh…
1 sources - 2 claims
The elevated cardiovascular death risk from clarithromycin persists after the medication is stopped. Taking clarithromycin is associated with a 27% increased risk of dying, primarily from cardiovascular events such as heart attack and arrhythmia.